Riskpilot← Back to searchSign inGet full accessSTRANDMOEN NÆRINGSUTVIKLING AS
ASActiveOrg 913670396Solbærvegen 5, 2409 ElverumManufacture of pharmaceutical preparations · NACE 2120Est. 20140 employees
Revenue 2024
NOK 75K
EBITDA margin
50.2%
+366% vs 2023
Equity ratio
99.7%
Financial strength
Net profit 2024
NOK -498K
+97% vs 2023
| Revenue | NOK 75K | — |
| EBITDA | NOK 38K | +366% |
| Net profit | NOK -498K | +97% |
| Total assets | NOK 672K | -43% |
| Equity | NOK 670K | -43% |
| Employees | 0 | — |
Legal name
STRANDMOEN NÆRINGSUTVIKLING AS
Org number
913670396
Legal form
Aksjeselskap
NACE code
2120 · Manufacture of pharmaceutical preparations
Founded
4. juni 2014
Share capital
NOK 166 338
Employees
0
VAT registered
No
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Styrets leder og ett styremedlem i fellesskap.
Company purpose
Eie selskaper som har som formål å etablere, utvikle og drive næringsvirksomhet med utgangspunkt i tilgjengelig kompetanse og anlegg på strandmoen i elverum, herunder å delta i andre selskaper med lignende virksomhet, kjøp og salg av aksjer, eller på annen måte gjøre seg interessert i andre foretagender. Primært vil selskapet engasjere seg i virksomheter innen produksjon av legemidler, medisinsk utstyr og kosttilskudd.
Address
Solbærvegen 5, 2409 Elverum
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 0 | 0 | 0 | 0 | 75 |
| Staff expenses | −0 | −0 | −0 | −0 | −0 |
| EBITDA | −7 | −9 | −8 | −14 | 38 |
| Depreciation & amort. | −0 | −0 | −0 | −0 | −0 |
| EBIT | −7 | −9 | −8 | −14 | 38 |
| Net financials | 0 | 0 | 1 | −17 061 | −536 |
| Profit before tax | −6 | −8 | −7 | −17 075 | −498 |
| Tax | −0 | −0 | −0 | −0 | −0 |
| Net profit | −6 | −8 | −7 | −17 075 | −498 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 13 363 | 15 589 | 18 247 | 1 180 | 672 |
| Equity | 13 363 | 15 589 | 18 243 | 1 168 | 670 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 |
| Short-term debt | 0 | 0 | 5 | 12 | 2 |
| Total debt | 0 | 0 | 5 | 12 | 2 |
EBITDA margin
50.2%
This company
15.8%
Market median
+218% vs market
20202024
Equity ratio
99.7%
This company
38.2%
Market median
+161% vs market
20202024
Return on equity
-74.4%
This company
18.4%
Market median
-504% vs market
20202024
Net profit margin
-664.3%
This company
8.1%
Market median
-8301% vs market
20202024
Asset turnover
0.11×
This company
1.12×
Market median
-90% vs market
20202024
Debt / equity
0.00×
This company
0.62×
Market median
+100% vs market
20202024
- Annual report 2024Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Brønnøysundsregistrene · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Brønnøysundsregistrene · Period 2020-01-01 – 2020-12-31
No data on file.
| Name | Role | Member since |
|---|---|---|
| Current (5) | ||
| Board of Directors | 2017 | |
| Chairman | 2017 | |
| Board of Directors | 2017 | |
| Board of Directors | 2017 | |
| Board of Directors | 2017 | |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Company | 18.3% | 18.3% | 2022 | |
| Company | 14.88% | 14.88% | 2022 | |
| Company | 7.15% | 7.15% | 2022 | |
| Company | 6.69% | 6.69% | 2022 | |
| Company | 5.87% | 5.87% | 2022 | |
| Individual | 4.95% | 4.95% | 2022 | |
| Company | 4.61% | 4.61% | 2022 | |
| Company | 1.92% | 1.92% | 2022 | |
| Company | 1.44% | 1.44% | 2022 | |
| Individual | 1.41% | 1.41% | 2022 | |
| Company | 1.29% | 1.29% | 2022 | |
| Individual | 1.23% | 1.23% | 2022 | |
| Individual | 1.19% | 1.19% | 2022 | |
| Individual | 1.08% | 1.08% | 2022 | |
| Individual | 1.08% | 1.08% | 2022 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
Skymoen Holding As
STRANDMOEN NÆRINGSUTVIKLING AS Board members of STRANDMOEN NÆRINGSUTVIKLING AS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Anne Simensen | Board of Directors | 0 companies |
| Per-Sveno Thoresen | Chairman | 0 companies |
| Tore Petter Bjørseth | Board of Directors | 0 companies |
| Arna Bækkedal | Board of Directors | 0 companies |
| Bjørn Ove Bertelsen | Board of Directors | 0 companies |